# TScan Therapeutics, Inc.: Form 8-K, filed Nov 3, 2025

- Company: [TScan Therapeutics, Inc.](/companies/tcrx.md) (CIK 1783328)
- Form: 8-K
- Filed: 2025-11-03
- Accepted by EDGAR: Nov 3, 2025, 06:35 ET
- Period: 2025-11-03
- Accession: 0001193125-25-261612
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1783328/000119312525261612/d873161d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1783328/000119312525261612/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1783328/000119312525261612/d873161d8k.htm

Filed Nov 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-261612. Last ingested by Listed: Nov 12, 2026, 17:50 ET. No prices; not investment advice.
